Imaging gene–substance interactions: The effect of the DRD2 TaqIA polymorphism and the dopamine agonist bromocriptine on the brain activation during the anticipation of reward

This publication has 16 references indexed in Scilit:

• Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
  Archives of Neurology, 2005
• Evidence for a common biological basis of the absorption trait, hallucinogen effects, and positive symptoms: Epistasis between 5-HT2a and COMT polymorphisms
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005
• Pathological gambling is linked to reduced activation of the mesolimbic reward system
  Nature Neuroscience, 2005
• Pleiotropic effect of the TPH A779C polymorphism on nicotine dependence and personality
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2005
• Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome
  American Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2004
• Catechol O -methyltransferase val ¹⁵⁸ -met genotype and individual variation in the brain response to amphetamine
  Proceedings of the National Academy of Sciences, 2003
• Ethanol consumption andDRD2gene TaqI a polymorphism among socially drinking males
  American Journal of Medical Genetics Part A, 2003
• Altered accumbens neural response to prediction of reward associated with place in dopamine D2 receptor knockout mice
  Proceedings of the National Academy of Sciences, 2002
• Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
  Molecular Psychiatry, 1999
• D2 dopamine receptor Gene TaqI A1 and B1 restriction fragment length polymorphisms: Enhanced frequencies in psychostimulant-preferring polysubstance abusers
  Biological Psychiatry, 1996